HeartSciences Inc.
HSCS
$3.70
$0.010.27%
NASDAQ
07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | |
---|---|---|---|---|---|
Net Income | -0.16% | -13.44% | -54.29% | -19.13% | -50.10% |
Total Depreciation and Amortization | -4.80% | 4.33% | 21.85% | 137.24% | 24.25% |
Total Amortization of Deferred Charges | -- | -- | 431.40% | -20.39% | -- |
Total Other Non-Cash Items | 170.28% | 43.78% | -72.48% | -81.30% | -71.24% |
Change in Net Operating Assets | -230.66% | 73.61% | 203.10% | -157.88% | 77.54% |
Cash from Operations | 3.23% | -0.88% | 22.89% | -120.97% | -43.75% |
Capital Expenditure | -- | 100.00% | 100.00% | 53.62% | -- |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 0.00% | 61.76% | 61.14% | -155.10% | 83.67% |
Cash from Investing | 0.00% | 88.73% | 68.09% | -190.00% | 83.67% |
Total Debt Issued | -- | -- | -- | 453.65% | -- |
Total Debt Repaid | -184.26% | 3.78% | -41.27% | 30.02% | 22.93% |
Issuance of Common Stock | -- | -62.03% | -97.26% | -56.73% | 54.01% |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | 561.28% | -73.48% | -98.03% | 269.55% | 70.07% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 215.41% | -18.10% | -120.86% | 39.50% | -35.32% |